Facebook
X
LinkedIn
Forward
Celiac Disease Across the Lifespan
Chicago, IL US
April 18, 2026
Advance Your Expertise in Celiac Disease Across the Lifespan!
Celiac disease is a complex, multifactorial condition that can emerge at any stage of life, from infancy to late adulthood, raising critical questions about triggers, diagnostic accuracy, and long-term management. With a strict gluten-free diet still the only effective therapy, clinicians and researchers are turning their attention to improved diagnostic methods, enhanced patient care, and the pursuit of future treatments.
Join leading national and international experts for a comprehensive, full-day symposium dedicated to the latest advances in celiac disease. This dynamic program will deliver focused, clinically relevant insights for providers across specialties, as well as researchers seeking a deeper understanding of disease mechanisms and emerging therapies.
Key topics include:
- Confident diagnosis and new diagnostic strategies, including gluten challenge protocols and noninvasive biomarkers
- Risk factors and screening approaches shaped by genetic and environmental influences
- Long-term patient management, follow-up care, and best practices for navigating pediatric-to-adult transitions
- Dietary counseling, nutritional monitoring, and optimizing adherence
- Psychosocial and behavioral aspects of living with celiac disease
- Complex presentations, misdiagnosis, and refractory celiac disease
Whether your work is patient-facing or research-focused, you’ll gain essential updates that can be applied immediately to practice. Don’t miss this opportunity to deepen your expertise, connect with leaders in the field, and stay ahead of rapidly evolving developments in celiac disease care and science!
Target Audience
This activity is designed for healthcare professionals, including physicians, basic scientists, healthcare professionals, registered dietitians, and others who are interested in learning more about celiac disease diagnosis, management, care, research updates, emerging diagnostic tools, and therapies.
Learning Objectives
After this activity, participants will be able to:
- Explain the immunopathogenic mechanisms underlying celiac disease and their relevance to clinical manifestations.
- Analyze genetic and environmental risk factors contributing to celiac disease development and their implications for population screening.
- Apply current diagnostic guidelines and recommendations to establish a secure diagnosis of celiac disease across pediatric and adult populations.
- Integrate multidisciplinary approaches to nutritional, psychological, and transitional care for patients with celiac disease across the lifespan.
- Evaluate recent advances in noninvasive monitoring tools for gluten exposure and their application in clinical practice.
- Appraise emerging therapies and research developments in celiac disease, including mechanisms of action and potential clinical applications.
You may also be interested in
| Time | Session | Faculty |
| 7:30 AM | Registration and Breakfast | |
| 7:50 AM | Welcome and Opening Remarks | Dr. Ritu Verma |
| Session 1: Making a Secure Diagnosis & Understanding Gluten-Related Disorders Associated with Celiac Disease Moderators: Dr. Verma & Dr. Lebwohl | ||
| 8:00 AM | Establishing a Secure Diagnosis | Dr. Edwin Liu |
| 8:20 AM | Managing Celiac Disease and Comorbidities | Dr. Marissa Stahl |
| 8:40 AM | Gluten Challenge | Dr. Jocelyn Silvester |
| 9:00 AM | T1D and Celiac Disease (Endocrine and Celiac Disease) | Dr. Katie O’Sullivan |
| 9:15 AM | Panel Discussion: Expert Perspectives on Diagnosis & Management Panelists: Drs. Liu, Stahl, Silvester, O’Sullivan | Moderators: Dr. Verma & Dr. Lebwohl |
| 9:30 AM | Break (15 mins) | |
| Session 2: Clinical Management of Celiac Disease Across the Lifespan Moderators: Dr. Silvester and Dr. Murray | ||
| 9:45 AM | Nutritional Management Across the Lifespan | Lori Welstead |
| 10:00 AM | Transitioning from Pediatric to Adult Celiac Care | Dr. Joseph Chapman |
| 10:15 AM | Psychosocial Aspects of Adherence and Disease Management | Dr. Alyse Bedell |
| 10:30 AM | Management of Nonresponsive and Refractory Celiac Disease | Dr. Carol Semrad |
| 10:45 AM | New Tools to Monitor Gluten Exposure (GIPs) | Dr. Sonia Kupfer |
| 11:00 AM | Panel Discussion – Managing Complex and Lifespan Challenges on Celiac Care Panelists: Drs. Welstead, Verma, Bedell, Semrad, Kupfer/Lebwohl | Moderators: Dr. Silvester and Dr. Murray |
| 11:15 AM | Lunch (1 Hour) | |
| Session 3: Risk Factors and the Development of Celiac Disease Across the Lifespan Moderators: Drs. Abadie & Dr. Jocelyn Silvester | ||
| 12:15 PM | Genetics of Celiac Disease: HLA and Beyond | Dr. Ludvig Sollid |
| 12:35 PM | Potential Celiac Disease | Dr. Renata Auricchio |
| 12:55 PM | Early Life Exposure and the Risk of Developing Celiac Disease | Dr. Daniel Agardh |
| 1:15 PM | The Microbiome and Celiac Disease | Dr. Elena Verdu |
| 1:35 PM | Somatic Mutations and Refractory Celiac Disease | Dr. Yichun Fu |
| 1:50 PM | Panel Discussion – Genetics, Environmental Triggers and the Development of Celiac Disease Panelists: Drs. Sollid, Auricchio, Agardh, Verdu, Fu | Moderators: Dr. Abadie & Dr. Silvester |
| 2:05 PM | Break (15 mins) | |
| Session 4: Advancing Research in Celiac Disease Moderators: Dr. Verdu and Dr. Sollid | ||
| 2:20 PM | Immunopathogenesis of Celiac Disease: From Established Pathways to Emerging Questions | Dr. Valerie Abadie |
| 2:40 PM | Translating Lab Findings into Therapeutic Development and Clinical Practice | Dr. Joe Murray |
| 3:00 PM | HDAC5 Controls the Effector Function of Cytotoxic CD8+ T Cells | Megan Borregard |
| 3:10 PM | Understanding the Mechanism of Tissue Healing and Recovery | Veronica Locher |
| 3:20 PM | New and Emerging Therapies | Keynote: Dr. Ben Lebwohl |
| 3:50 PM | Panel Discussion – The Future of Celiac Disease Research Panelists: Drs. Abadie, Murray, Sollid, Locher, Borregard, Lebwohl | Moderator: Dr. Sollid |
| 4:05 PM | Concluding Remarks | Dr. Abadie |
The agenda is subject to change.
David Rubenstein Forum at the University of Chicago
1201 E 60th St
Chicago, IL
60637
United States
DAVID RUBENSTEIN FORUM
The David Rubenstein Forum combines a variety of spaces, both formal and informal, large and small, calm and animated, focused and diffuse, scheduled and spontaneous. Its ten-story tower features vibrant and distinct “neighborhoods.” For example, the third and fourth floors are home to Friedman Hall, a 285-seat auditorium optimized for spoken word, including keynote speeches, invited-speaker addresses, and select performances; these floors and other neighborhoods are connected by a two-story lounge. Meeting rooms on the eighth and ninth floors feature premium furnishings, finishes, and equipment, such as the Peter May Boardroom, a tiered meeting space that seats over 70. The Rubenstein Forum’s unique position on the Midway allows for expansive views toward the campus and surrounding communities as well as downtown Chicago and Lake Michigan.
VISITING CHICAGO
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic ninth year in a row. To help plan your stay in Chicago, visit Choose Chicago.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via email.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, the University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTORS
Ritu Verma, MD
Professor of Pediatrics
Chief, Section of Pediatric Gastroenterology, Hepatology, and Nutrition
Medical Director, Celiac Disease Center
Professor of Pediatrics
Chief, Section of Pediatric Gastroenterology, Hepatology, and Nutrition
Medical Director, Celiac Disease Center
Valerie Abadie
Research Associate Professor of Medicine
Research Associate Professor of Medicine
Disclosure Declarations
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 6.5 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 6.5 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit-claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
HOW TO REGISTER
Please log in or create an account to register. Once logged in, select the registration type that best suits you. For help, follow our 
registration guide.
registration guide.| Profession Type | Fee |
| Physician | $150 |
| Other Healthcare Professional | $125 |
| Trainee | $100 |
| Industry | $250 |
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee, less a 50% administrative fee, will be refunded when written notification is received by March 18, 2026. No refunds will be made after March 18, 2026. | |
HOW TO CLAIM CREDIT
After the activity, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please note: The credit-claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please note: The credit-claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.